Şebnem Ataman

Efficacy and safety of tofacitinib monotherapy, tofacitinib with methotrexate, and adalimumab with methotrexate in patients with rheumatoid arthritis (ORAL Strategy): a phase 3b/4, double-blind, head-to-head, randomised controlled trial

Roy Fleischmann, Eduardo Mysler, Stephen Hall et al. · The Lancet · 2017 · 479 citations

Rheumatoid Disorder, Rheumatology, Tofacitinib Monotherapy +8

Issues in cross‐cultural validity: Example from the adaptation, reliability, and validity testing of a Turkish version of the Stanford Health Assessment Questionnaire

Ayşe A. Küçükdeveci, Hülya Şahin, Şebnem Ataman et al. · Arthritis Care & Research · 2004 · 283 citations

Quality of life and related variables in patients with ankylosing spondylitis

Hatice Bodur, Şebnem Ataman, Aylin Rezvanı et al. · Quality of Life Research · 2010 · 124 citations

Rheumatology, Quality Of Life, Life Assessment +6

Characteristics and medical management of patients with rheumatoid arthritis and ankylosing spondylitis

Hatice Bodur, Şebnem Ataman, Lale Akbulut et al. · Clinical Rheumatology · 2008 · 44 citations

Rheumatoid Disorder, Rheumatology, Rheumatic Diseases +7

Serum C-Reactive Protein/Albumin Ratio in Rheumatoid Arthritis and its Relationship With Disease Activity, Physical Function, and Quality of Life

İsmihan Sunar, Şebnem Ataman · Archives of Rheumatology · 2020 · 43 citations · Full text